POST LEONARD E
Reporting owner on Forms 3, 4 and 5, CIK 1235862.
POST LEONARD E reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CGON · CG Oncology, Inc.CIK 1991792 | director | 2 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CGON · CG Oncology, Inc.Common Stock | 2026-11-16 | M exercised | +1,000 | $0.6 | 1,000 | Form 4 |
| CGON · CG Oncology, Inc.Common Stock | 2026-11-16 | S sold | -1,000 | $92 | 1,000 | Form 4 |
| CGON · CG Oncology, Inc.Director Stock Option (right to buy), derivative | 2026-11-16 | M exercised | -1,000 | $0 | 101,077 | Form 4 |
| CGON · CG Oncology, Inc.Common Stock | 2026-10-15 | M exercised | +1,000 | $0.6 | 1,000 | Form 4 |
| CGON · CG Oncology, Inc.Common Stock | 2026-10-15 | S sold | -500 | $61.65 | 500 | Form 4 |
| CGON · CG Oncology, Inc.Common Stock | 2026-10-15 | S sold | -500 | $62.48 | 0 | Form 4 |
| CGON · CG Oncology, Inc.Director Stock Option (right to buy), derivative | 2026-10-15 | M exercised | -1,000 | $0 | 102,077 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-465593 | CG Oncology, Inc. | 2026-11-17 | ||
| Form 4 0001193125-26-425295 | CG Oncology, Inc. | 2026-10-19 |